Fujifilm Debuts Synapse Pathology at the Healthcare Information and Management Systems Society 2023 Annual Meeting
Company will also showcase its full Synapse® Organization Imaging portfolio in booth #2801
Lexington, Mass., April 14, 2023 (World NEWSWIRE) — FUJIFILM Health care Americas Corporation, a top supplier of organization imaging and informatics alternatives, will debut Synapse Pathology, the company’s freshly obtained and branded electronic pathology PACS remedy at the 2023 Healthcare Details and Management Programs Culture (HIMSS) annual conference in booth #2801. Synapse Pathology is an open, seller-agnostic, finish-to-conclusion alternative designed for health care facilities that cope with big volumes of pathology photos and information across multiple locations. Synapse Pathology provides digital images for prognosis 1.7 hrs a lot quicker* than glass slides and facilitates instantaneous sharing of individual conditions with subspecialists to greatly enhance cross-departmental collaboration and diagnostic performance.
Synapse Pathology was intended to seamlessly assist the artwork of precision diagnostics for pathologists. The application uses complete slide illustrations or photos from several scanning vendors to develop a straightforward route for pathology digitization across laboratories. This digitization makes it possible for laborites to understand the benefits of faster individual outcomes, centralized imaging data, and business obtain to photographs for all clinicians. The method makes use of an intuitive person interface to place the applications each individual pathologist desires at their fingertips. The remedy also consists of an on the net digital assistant to support pathologists navigate situation facts and provides resources for measurements, annotations, collaboration, and messaging.
“The addition of Pathology to our company imaging portfolio is remarkable for us, as it aligns with our skills and strengths in the location of digitizing healthcare imaging and supporting vendors efficiently changeover to all the positive aspects of digital workflow” suggests Monthly bill Lacy, senior vice president, healthcare informatics, FUJIFILM Health care Americas Company. “We in no way lose sight of the even larger photo when introducing new innovation, and now as Pathology evolves to embrace all of the new rewards of electronic imaging with Synapse Pathology, we will also be leveraging our award-successful Synapse Company Imaging portfolio to bring Pathology into the workflow of the health care enterprise.”
HIMSS attendees will also get to experience the following healthcare informatics innovations from Fujifilm:
-
Synapse 7x, Fujifilm’s next-generation enterprise PACS unites radiology, cardiology and company imaging knowledge via a solitary, zero-footprint PACS viewer by using cloud-based mostly and on-premises hosting. The solution also presents extensive superior visualization applications and has Fujifilm’s award-successful VNA at the main.
-
Integral to Synapse 7x, Synapse Radiology and Cardiology PACS is developed with ongoing direction from radiologists and cardiologists. Fujifilm’s Synapse PACS is a strong server-facet rendering resolution that aids streamline diagnostic impression investigation, enrich material obtain and streamline workflow.
-
Synapse Analytics, the company’s cloud-dependent knowledge mining motor that permits healthcare companies to analyze business knowledge to see present-day and predictive views of their organization functions
-
Synapse 3D Superior Visualization brings 3D rendered illustrations or photos and advanced visualization workflows to all Synapse users throughout a number of specialties including radiology, cardiology, and surgery
-
Awarded Ideal-in-KLAS for 4 consecutive many years, Synapse VNA seamlessly captures, stores, and manages all medical images and information from every single company line—regardless of the building resource, structure form, or siloed storage system
-
Synapse Company Information and facts Procedure (EIS), is a in depth workflow management alternative that expands over and above radiology to help just about every aspect of the imaging business enterprise. The solution seamlessly streamlines radiologist and staff workflows, support care excellent, and improve efficiency all through the entire individual encounter
-
Synapse AI Platform, which utilizes open APIs to aid intensive Fujifilm and 3rd-bash algorithms together with an state-of-the-art guidelines engines, to deliver providers chosen algorithms immediately inside of Synapse PACS workflow
Also at booth #2801, Fujifilm will showcase FUJIFILM Sonosite’s Synchronicity™ workflow manager, which gives optimized issue-of-care ultrasound (POCUS) workflows across all scientific roles, and inside of and across departments for consistency of care.
To find out much more about Fujifilm’s presence at HIMSS 2023 and to schedule an on-web site assembly, remember to click on in this article.
*Lujan G, Kellough DA, Frankel WL, Chhibber NN, Parwani AV, Chen W, Li Z, Lombardo A, Walsh J, Lloyd M. More quickly Than Glass: A Electronic Pathology Workflow Unlocks Big Time-Savings. United States & Canadian Academy of Pathology’s (USCAP) 111th Annual Conference. Los Angeles, CA. March 19-24, 2022.
About Fujifilm
FUJIFILM Healthcare Americas Company is a complete healthcare enterprise that has an comprehensive variety of technological innovation and skills in the detection, prognosis and therapy of ailments. Fujifilm’s progressive clinical imaging portfolio incorporates alternatives for electronic radiography, mammography, CT, MRI, ultrasound, gastroenterology, pulmonology, endosurgery, and minimally invasive surgical procedure. The award-winning Synapse® Business Imaging portfolio supplies health care industry experts with the cross-departmental imaging and facts accessibility essential to produce a total affected person report. Fujifilm’s AI initiative, REiLI®, combines Fujifilm’s wealthy image-processing heritage with cutting-edge AI innovations to inspire clinical confidence and fight burnout. The In-Vitro Diagnostic portfolio gives the gold standard of molecular centered immunoassay technological know-how for liver surveillance, chopping edge medical diagnostic substances for top laboratories and diagnostic chemicals for OEM white labelling solutions. The organization is headquartered in Lexington, Massachusetts. Click on listed here for extra facts.
FUJIFILM Company is an functioning corporation of FUJIFILM Holdings Company. FUJIFILM Holdings Corporation, Tokyo, leverages its depth of awareness and proprietary core systems to produce Benefit from Innovation in its goods and products and services in the business segments of health care, supplies, business enterprise innovation, and imaging. Its relentless pursuit of innovation is concentrated on furnishing social price and enhancing the lives of men and women globally. Fujifilm is dedicated to liable environmental stewardship and great corporate citizenship. For far more info about Fujifilm’s Sustainable Value Strategy 2030, click here. For the year ended March 31, 2022, the firm had international revenues of about 2.5 trillion yen (21 billion $USD at an trade amount of 122 yen/dollar). For much more information and facts, make sure you visit: www.fujifilmholdings.com.
Make contact with: Danielle Brown FUJIFILM Holdings The united states Corporation 914-574-3273 [email protected]
